Cargando…

What Are the bona fide GSK3 Substrates?

Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identifica...

Descripción completa

Detalles Bibliográficos
Autor principal: Sutherland, Calum
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100594/
https://www.ncbi.nlm.nih.gov/pubmed/21629754
http://dx.doi.org/10.4061/2011/505607
_version_ 1782204201577742336
author Sutherland, Calum
author_facet Sutherland, Calum
author_sort Sutherland, Calum
collection PubMed
description Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition.
format Text
id pubmed-3100594
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-31005942011-05-31 What Are the bona fide GSK3 Substrates? Sutherland, Calum Int J Alzheimers Dis Review Article Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition. SAGE-Hindawi Access to Research 2011-05-18 /pmc/articles/PMC3100594/ /pubmed/21629754 http://dx.doi.org/10.4061/2011/505607 Text en Copyright © 2011 Calum Sutherland. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sutherland, Calum
What Are the bona fide GSK3 Substrates?
title What Are the bona fide GSK3 Substrates?
title_full What Are the bona fide GSK3 Substrates?
title_fullStr What Are the bona fide GSK3 Substrates?
title_full_unstemmed What Are the bona fide GSK3 Substrates?
title_short What Are the bona fide GSK3 Substrates?
title_sort what are the bona fide gsk3 substrates?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100594/
https://www.ncbi.nlm.nih.gov/pubmed/21629754
http://dx.doi.org/10.4061/2011/505607
work_keys_str_mv AT sutherlandcalum whatarethebonafidegsk3substrates